Genetics of 35 blood and urine biomarkers in the UK Biobank

Clinical laboratory tests are a critical component of the continuum of care and provide a means for rapid diagnosis and monitoring of chronic disease. In this study, we systematically evaluated the genetic basis of 38 blood and urine laboratory tests measured in 358,072 participants in the UK Biobank and identified 1,857 independent loci associated with at least one laboratory test, including 488 large-effect protein truncating, missense, and copy-number variants. We tested these loci for enrichment in specific single cell types in kidney, liver, and pancreas relevant to disease aetiology. We then causally linked the biomarkers to medically relevant phenotypes through genetic correlation and Mendelian randomization. Finally, we developed polygenic risk scores (PRS) for each biomarker and built multi-PRS models using all 38 PRSs simultaneously. We found substantially improved prediction of incidence in FinnGen (n=135,500) with the multi-PRS relative to single-disease PRSs for renal failure, myocardial infarction, liver fat percentage, and alcoholic cirrhosis. Together, our results show the genetic basis of these biomarkers, which tissues contribute to the biomarker function, the causal influences of the biomarkers, and how we can use this to predict disease.

[1]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[2]  Dermot F. Reilly,et al.  Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease , 2018 .

[3]  Matthew Aguirre,et al.  Phenome-wide burden of copy number variation in UK Biobank , 2019, bioRxiv.

[4]  G. Abecasis,et al.  Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis , 2018, bioRxiv.

[5]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[6]  T. Hankemeier,et al.  Genome-wide association study of plasma lipids , 2019, bioRxiv.

[7]  M. Pirinen,et al.  Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA , 2016, Nature Communications.

[8]  Evan Z. Macosko,et al.  Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types , 2017, Nature Genetics.

[9]  S. Hillier,et al.  Oestradiol Assays: Applications and Guidelines for the Provision of a Clinical Biochemistry Service , 1988, Annals of clinical biochemistry.

[10]  Alexander Pertsemlidis,et al.  Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 , 2005, Nature Genetics.

[11]  M. Rivas,et al.  Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study , 2018, Nature Communications.

[12]  N. Lundbom,et al.  Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. , 2009, Gastroenterology.

[13]  Alicia R. Martin,et al.  Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.

[14]  J. Stockman,et al.  A New Equation to Estimate Glomerular Filtration Rate , 2011 .

[15]  P. O’Reilly,et al.  Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels , 2018, Nature Communications.

[16]  P. Visscher,et al.  Complex Trait Prediction from Genome Data: Contrasting EBV in Livestock to PRS in Humans , 2019, Genetics.

[17]  Cathie Sudlow,et al.  Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank , 2016, PloS one.

[18]  C. Smith,et al.  γδ T cells promote inflammation and insulin resistance during high fat diet‐induced obesity in mice , 2015, Journal of leukocyte biology.

[19]  Beata Franczyk,et al.  Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome , 2017, International journal of molecular sciences.

[20]  Sylvia Stracke,et al.  Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes , 2015, Diabetes.

[21]  R. D'Agostino,et al.  A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study , 2007, BMC Medical Genetics.

[22]  G. Bell,et al.  Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. , 1997, Nature genetics.

[23]  David A. Knowles,et al.  Inferring relevant cell types for complex traits using single-cell gene expression , 2017, bioRxiv.

[24]  Tanya M. Teslovich,et al.  Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease , 2017, The New England journal of medicine.

[25]  H. Yki-Järvinen.  Fat in the liver and insulin resistance , 2005, Annals of medicine.

[26]  Christian Gieger,et al.  Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis , 2017, PLoS Medicine.

[27]  Raquel S. Sevilla,et al.  Exome-wide association study of plasma lipids in >300,000 individuals , 2017, Nature Genetics.

[28]  B. Neale,et al.  Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases , 2018, Nature Genetics.

[29]  Amita Sharma,et al.  Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis. , 2014, Journal of the American Society of Nephrology : JASN.

[30]  B. Pasaniuc,et al.  Contrasting the genetic architecture of 30 complex traits from summary association data , 2016, bioRxiv.

[31]  Jonathan C. Cohen,et al.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. , 2006, The New England journal of medicine.

[32]  J. Takeda,et al.  Frameshift Mutation, A263fsinsGG, in the Hepatocyte Nuclear Factor-1β Gene Associated With Diabetes and Renal Dysfunction , 1998, Diabetes.

[33]  M. Kanai,et al.  Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases , 2018, Nature Genetics.

[34]  A. Price,et al.  Distinguishing genetic correlation from causation across 52 diseases and complex traits , 2017, Nature Genetics.

[35]  Y. J. Kim,et al.  Meta-analysis identifies multiple loci associated with kidney function–related traits in east Asian populations , 2012, Nature Genetics.

[36]  Trevor Hastie,et al.  A Fast and Flexible Algorithm for Solving the Lasso in Large-scale and Ultrahigh-dimensional Problems , 2019 .

[37]  Cardiovascular endocrinology: Is ANGPTL3 the next PCSK9? , 2017, Nature Reviews Endocrinology.

[38]  Bogdan Pasaniuc,et al.  Local genetic correlation gives insights into the shared genetic architecture of complex traits , 2016, bioRxiv.

[39]  Jonathan C. Cohen,et al.  Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. , 2010, The New England journal of medicine.

[40]  Y. Iwamoto,et al.  Liver and Kidney Function in Japanese Patients With Maturity-Onset Diabetes of the Young , 1998, Diabetes Care.

[41]  Cassandra N. Spracklen,et al.  Identification and functional analysis of glycemic trait loci in the China Health and Nutrition Survey , 2018, PLoS genetics.

[42]  G. Breen,et al.  Multi-polygenic score approach to trait prediction , 2017, Molecular Psychiatry.

[43]  Hiroyuki Kuroki,et al.  Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY , 1997, Nature Genetics.

[44]  Tanya M. Teslovich,et al.  Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways , 2012, Nature Genetics.

[45]  E. Rimm,et al.  A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. , 1993, The New England journal of medicine.

[46]  V. M. V. Program.  A catalog of genetic loci associated with kidney function from analyses of a million individuals , 2019 .

[47]  Audrey Y. Chu,et al.  1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function , 2017, Scientific Reports.

[48]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[49]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[50]  Eric Boerwinkle,et al.  Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. , 2008, The Journal of clinical investigation.

[51]  Christopher M. DeBoever,et al.  Components of genetic associations across 2,138 phenotypes in the UK Biobank highlight novel adipocyte biology , 2018, bioRxiv.

[52]  R. Tibshirani.  Regression Shrinkage and Selection via the Lasso , 1996 .

[53]  M. Pontoglio,et al.  AKT2 is essential to maintain podocyte viability and function during chronic kidney disease , 2013, Nature Medicine.

[54]  Fabian J Theis,et al.  Genome-wide association analyses identify 18 new loci associated with serum urate concentrations , 2012, Nature Genetics.

[55]  Dajiang J. Liu,et al.  Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants contributing to lipid levels and coronary artery disease , 2017, Nature Genetics.

[56]  Tanya M. Teslovich,et al.  Genetics of Blood Lipids Among ~300,000 Multi-Ethnic Participants of the Million Veteran Program , 2018, Nature Genetics.

[57]  M. Daly,et al.  An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.

[58]  Christian Gieger,et al.  Discovery and Fine-Mapping of Glycaemic and Obesity-Related Trait Loci Using High-Density Imputation , 2015, PLoS genetics.

[59]  H. Zou,et al.  Regularization and variable selection via the elastic net , 2005 .

[60]  Alexander Gusev,et al.  Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights , 2016, Nature Genetics.

[61]  Jin-an Zhang,et al.  Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis , 2017, Endocrine connections.

[62]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[63]  Stefan Neubauer,et al.  Characterisation of liver fat in the UK Biobank cohort , 2017, PloS one.

[64]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[65]  Karsten B. Sieber,et al.  A catalog of genetic loci associated with kidney function from analyses of a million individuals , 2019, Nature Genetics.

[66]  Mingyao Li,et al.  Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease , 2018, Science.

[67]  Janan T. Eppig,et al.  Expanding the mammalian phenotype ontology to support automated exchange of high throughput mouse phenotyping data generated by large-scale mouse knockout screens , 2015, Journal of Biomedical Semantics.

[68]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[69]  J. Hokanson,et al.  Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease. , 2009, Diabetes technology & therapeutics.

[70]  Valeriia Haberland,et al.  The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.

[71]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[72]  V. Bird,et al.  A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney Stones , 2021, 50 Studies Every Urologist Should Know.